Questions discussed in this category
Specifically, do you offer closer follow-up for certain patients after local radiation?
I.e. dosing regimen frequency, side effect profile, duration of follow up, etc.
Do you utilize rituximab or any other specific management strategies?
Frailty Index per Palumbo et al. PMID 25628469Is it practical to apply in clinics? Have you made decision changes based on it?
CAR-T (any specific preference of product?) vs bispecific antibodies vs any other specific agents not previously utilized?
1891118411177261670417254170101572916578152831490114489142091391911769121781155710594
Papers discussed in this category
The New England journal of medicine, 2012-05-10
Nature communications, 2019-04-23
Blood, 2012 Aug 13
J Clin Oncol, 2020 Apr 16
Blood,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-10-10
The New England journal of medicine, 2017-04-06
The Lancet. Oncology, 2019-01
Blood,
Blood, 2015-03-26
Clin Lymphoma Myeloma Leuk, 2019 Oct 09
JCO Oncol Pract, 2019 Nov 25
Proc Natl Acad Sci U S A, 2019 Apr 15
N Engl J Med,
N Engl J Med,
Clin Lymphoma Myeloma Leuk, 2020 Jul 29
Br J Haematol, 2021 Aug 15
Blood, 2022 Dec 08
Leukemia, 2019-03
Leukemia, 2022 Feb 21
Lancet, 2021 Jun 24
N Engl J Med, 2023 Jun 05
N Engl J Med, 2023 Feb 10
Lancet Oncol, 2021 Dec 03
Lancet, 2021 Jun 04
Br J Haematol, 2023 Jun 07
J Clin Oncol, 2021 Aug 13
The Lancet. Haematology, 2023 Sep 11
The Lancet. Oncology, 2021 Sep 13
The New England journal of medicine, 2019-05-30
Blood, 2023 Nov 30
Cancer, 2011-10-01
BMC Cancer, 2006 May 05
International journal of radiation oncology, biology, physics, 1998-07-15
International journal of radiation oncology, biology, physics, 2006-01-01
Blood, 2014 May 29
Blood, 2014 Jun 17
International journal of radiation oncology, biology, physics, 2011 Jan 27